Top Markets
#1 GENIUS AI GENIUS AI +167.52%
#2 Siren Siren +17.98%
#3 WAX WAX +15.05%
#4 Cloud Cloud +11.86%
#5 GXChain GXChain +9.63%
#6 Giggle Fund Giggle Fund +9.45%
#7 Strategic Oil Supply Strategic Oil Supply +8.98%
#8 SmarDex SmarDex +8.60%
#9 ZetaChain ZetaChain +8.55%
#10 StakeStone StakeStone +7.88%
Coin of the day
GENIUS AI GENIUS AI
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Gilead Sciences, Inc. Gilead Sciences, Inc.

Gilead Sciences, Inc.

GILD
Rang in aandelen #93
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and... Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Gadeta B.V.; Bristol-Myers Squibb Company; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.
Aandeelprijs
$137.21
Marktkapitalisatie
$170.34B
Verandering (1 dag)
-2.76%
Verandering (1 jaar)
28.14%
Land
US
Handel Gilead Sciences, Inc. (GILD)

Categorie

Healthcare
Dividendrendementgeschiedenis voor Gilead Sciences, Inc. (GILD)
Het dividendrendement (TTM) van Gilead Sciences, Inc. (aandelsymbool: GILD) per 2024-12-31 is: 3.40%
Gemiddeld dividendrendement over de afgelopen 5 jaar: 3.43%
Dividendrendementgeschiedenis van Gilead Sciences, Inc. (GILD) van 2000 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
2026 (TTM) 2.20% -14.40%
2025 2.57% -24.41%
2024 3.40% -9.81%
2023 3.77% 9.59%
2022 3.44% -12.91%
2021 3.95% -16.14%
2020 4.71% 20.77%
2019 3.90% 6.56%
2018 3.66% 25.34%
2017 2.92% 14.06%
2016 2.56% 101.57%
2015 1.27% 0.00%
2014 0.00% 0.00%
2013 0.00% 0.00%
2012 0.00% 0.00%
2011 0.00% 0.00%
2010 0.00% 0.00%
2009 0.00% 0.00%
2008 0.00% 0.00%
2007 0.00% 0.00%
2006 0.00% 0.00%
2005 0.00% 0.00%
2004 0.00% 0.00%
2003 0.00% 0.00%
2002 0.00% 0.00%
2001 0.00% 0.00%
2000 0.00% 0.00%
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten
Bedrijf Dividendrendement Land
Eli Lilly Eli Lilly
Eli Lilly
LLY.US
0.63%
US
AstraZeneca PLC AstraZeneca PLC
AstraZeneca PLC
AZN.US
1.64%
GB
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
2.15%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
3.03%
US
Novartis AG Novartis AG
Novartis AG
NVS.US
3.05%
CH